Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.5 SEK | -2.61% | -7.19% | -31.73% |
05-15 | Genovis AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-14 | Carthesian Therapeutics Terminates Genovis AB (Publ.) Licence Agreement | CI |
End-of-day quotes
Sector Diagnostic & Testing Substances
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
220M | ||||||
11.98B | ||||||
8B | ||||||
5.85B | ||||||
5.54B | - | - | ||||
3.84B |
- Stock Market
- Equities
- GENO Stock
- Charts Genovis AB
- Sector Chart